| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/08/1993 | CA2075543A1 Use of adenosine compounds in the treatment of ischaemia |
| 02/04/1993 | WO1993002188A1 Universal donor cells |
| 02/04/1993 | WO1993002099A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
| 02/04/1993 | WO1993002090A1 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 02/04/1993 | WO1993002048A1 Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof |
| 02/04/1993 | WO1993001813A1 Platelet activating factor antagonists |
| 02/04/1993 | DE4125024A1 Arzneimittel auf pflanzlicher basis zur tonuserhoehung und zur tonusmodulierung der glatt muskulaeren organe Medicinal plant-based to an increase in tone and tonusmodulierung smooth muscle organs |
| 02/04/1993 | CA2113358A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
| 02/04/1993 | CA2112562A1 Platelet activating factor antagonists |
| 02/03/1993 | WO1993003013A1 Indoline derivatives having an amide function, their preparation, and pharmaceutical compositions containing them |
| 02/03/1993 | EP0526434A1 Benzimidazolone derivatives as 5-HT1A and 5-HT2 antagonists |
| 02/03/1993 | EP0526348A1 Indoline derivatives carrying an amide function, their preparation and pharmaceutical compositions containing them |
| 02/03/1993 | EP0526342A1 Isoquinolin-5yl-sulphonamides, process for their preparation and pharmaceutical compositions containing them |
| 02/03/1993 | EP0526192A2 Hexapeptide |
| 02/03/1993 | EP0526004A1 Pyrazolopyrimidinone antianginal agents |
| 02/03/1993 | EP0526001A1 Substituted triazolinones |
| 02/03/1993 | EP0525973A2 Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 02/03/1993 | EP0525768A1 Tetralones with pharmacological activity |
| 02/03/1993 | EP0525571A1 Quinolin-2-yl-methoxybenzylhydroxyureas as lipoxygenase inhibitors |
| 02/03/1993 | EP0525472A2 Methylen-oxindole derivatives and process for their preparation |
| 02/03/1993 | EP0525420A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors |
| 02/03/1993 | EP0525129A1 Substituted benzimidazoles |
| 02/03/1993 | EP0525109A1 Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit egf receptor tyrosine kinase |
| 02/03/1993 | EP0386076B1 Phosphoryled derivatives of cardiodilatine/anf peptides |
| 02/03/1993 | EP0349545B1 New cardiodilatin fragment, process for preparing same and use thereof |
| 02/02/1993 | USH1139 Combination of a calcium channel blocker and thromboxane A2 receptor antagonist or synthetase inhibitor and method for treating ischemia employing such combination |
| 02/02/1993 | CA2075010A1 Aryl, amide, imide, and carbamate pyridine antagonists of platelet activating factor |
| 02/02/1993 | CA1313371C Fused azepinone and azocinone derivatives, processes for their preparation, agents containing them and their use, and intermediates in their preparation |
| 02/01/1993 | CA2075017A1 (isoquinolein-5-yl) sulfonamides, process for their prepara tion and pharmaceutical compositions containing them |
| 02/01/1993 | CA2074963A1 New n-[(isoquinolein-5-yl)sulfonyl] azacycloalcanes, preparation process and pharmaceutical compositions containing them |
| 02/01/1993 | CA2074788A1 Qinolin-2-yl-methoxybenzylhydroxyureas |
| 01/31/1993 | CA2074967A1 Hexapeptide |
| 01/31/1993 | CA2074864A1 Tetralones with pharmacological activity |
| 01/27/1993 | EP0524595A1 Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof |
| 01/27/1993 | EP0524553A1 Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use |
| 01/27/1993 | EP0524512A2 Antihypertensive combinations |
| 01/27/1993 | EP0524190A1 Hmg-co a reductive inhibitors |
| 01/27/1993 | CN1068329A Pyrazolopyrimidinone antianginal agents |
| 01/26/1993 | WO1993001803A1 Controlled release verapamil tablet |
| 01/26/1993 | US5182294 Imidazolyl propyl guanidine derivative and a pharmaceutical composition containing this compound |
| 01/26/1993 | US5182288 Substituted n-biphenylyl lactams |
| 01/26/1993 | US5182272 8-substituted-dibenz[b,f][1,4]oxazepine-10(11)-carboxylic acid, substituted hydrazides, pharmaceutical compositions, and methods for treating pain |
| 01/26/1993 | CA1313139C D1-5-[(2-benzyl-3,4-dihydro-2h-benzopyran-6-yl)methyl] thiazolidine-2,4-dione as an anti-atherosclerosis agent |
| 01/21/1993 | WO1993001215A1 Pla2 inhibitory compounds |
| 01/21/1993 | WO1993001182A1 Methylen-oxindole derivatives and process for their preparation |
| 01/21/1993 | WO1993001177A1 Substituted triazolinones |
| 01/21/1993 | WO1993001170A1 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| 01/21/1993 | WO1993001163A1 Amino acid derivative |
| 01/21/1993 | WO1993000893A1 Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients |
| 01/21/1993 | WO1992019211A3 Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same |
| 01/21/1993 | CA2111345A1 Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients |
| 01/20/1993 | EP0524161A1 Manganese complexes of nitrogen containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 01/20/1993 | EP0524004A1 Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo[2,3-e]quinolizine derivatives |
| 01/20/1993 | EP0523141A1 Substituted pyrazoles, isoxazoles and isothiazoles |
| 01/20/1993 | EP0523138A1 Novel derivatives of phenyl-cycloalkanes and -cycloalkenes |
| 01/20/1993 | EP0523086A1 Pharmaceutical aqueous solution of 4- 2-(benzolsulphonylamino)-ethyl]-phenoxyacetic acid |
| 01/20/1993 | CN1068117A Heterocyclic compounds with renin-inhibiting properties, process for preparation thereof and use thereof |
| 01/20/1993 | CN1068112A Compounds with renin-inhibiting properties, process for the preparation thereof and use thereof |
| 01/19/1993 | US5180742 Lipoxygenase Inhibitors |
| 01/19/1993 | US5180723 Certain sulfonamide heterobicyclic platelet activating factor antagonists |
| 01/19/1993 | CA1312871C Indene and naphthalene derivatives |
| 01/19/1993 | CA1312866C Benzo¬b|pyranes and pyranopyridines, process for their production and their use |
| 01/18/1993 | CA2074038A1 Decahydro-8h-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a] pyrrol[2,3-e]quinolizine derivatives |
| 01/13/1993 | WO1993000901A1 Pharmaceutical compositions |
| 01/13/1993 | EP0522494A1 Novel isatineoxime derivatives, their preparation and use |
| 01/13/1993 | EP0522433A1 Oral aqueous solutions containing ubidecarenone |
| 01/13/1993 | EP0522431A1 Phophorus-containing HMG-COA reductase inhibitors |
| 01/13/1993 | EP0522226A1 Eyedrop solution for the treatment of ocular hypertension containing ketauserin |
| 01/13/1993 | EP0522176A1 Dihydropyridine compounds, and process for their preparation |
| 01/13/1993 | EP0522038A1 Substituted pyrimidines, pyrimidinones and pyridopyrimidines |
| 01/13/1993 | EP0522000A1 5-lipoxygenase inhibitors |
| 01/13/1993 | EP0521963A1 Crf analogs |
| 01/13/1993 | EP0521936A1 Unsaturated n-benzoxodiazopyranyl lactams, their production and use |
| 01/13/1993 | EP0275249B1 Continuous intravenous infusion of adenosine to human patients, a unit dosage form of adenosine and use of adenosine for the manufacture of medicaments |
| 01/13/1993 | CA2091251A1 Pharmaceutical compositions |
| 01/12/1993 | US5179216 Anticholesterol agents and atherosclerosis |
| 01/12/1993 | US5179206 Substituted 3-aminosydnone imines |
| 01/12/1993 | US5179108 Derivatives of 4-(aminomethyl) piperidine, their preparation and their therapeutic application |
| 01/12/1993 | US5178855 Treatment of luekocyte dysfunction with GM-CSF |
| 01/12/1993 | CA1312549C Instant oral-release capsule containing nifedipine |
| 01/11/1993 | CA2072394A1 Phosphorus-containing hmg-coa reductase inhibitors |
| 01/10/1993 | CA2073281A1 Isatineoxime derivatives, their preparation and use |
| 01/07/1993 | WO1993000341A1 4-(1-h-pyrrol-1-yl)imidazoles with angiotensin ii antagonist activity |
| 01/07/1993 | WO1993000335A1 Tetrahydrobenzazepine derivatives which inhibit lipoxygenase |
| 01/07/1993 | WO1993000332A1 Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 01/07/1993 | WO1993000313A2 Sigma receptor ligands and the use thereof |
| 01/07/1993 | WO1993000097A1 Pharmaceutical preparations containing torasemid |
| 01/07/1993 | WO1993000095A2 Bicyclic fibrinogen antagonists |
| 01/07/1993 | WO1993000094A2 Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine |
| 01/07/1993 | WO1993000052A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | WO1993000051A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | EP0521768A1 Thiazolopyrimidine derivatives as angiotensin II-receptor antagonists: processes for their preparation and pharmaceutical compositions containing them |
| 01/07/1993 | EP0521471A1 Pyrimidine derivatives as HMG-CoA reductase inhibitors |
| 01/07/1993 | EP0521464A1 Antibiotic, phencomycin, a process for its production and its use |
| 01/07/1993 | EP0521422A1 Benzomorphanes and their use as pharmaceuticals |
| 01/07/1993 | EP0521310A2 Solid dispersion tablets containing 1,4-dihydropyridine derivatives and process for the preparation thereof |
| 01/07/1993 | EP0521009A1 5-trans-prostaglandin-2-alpha as an ocular hypotensive agent |
| 01/07/1993 | DE4120990A1 Verfahren zur herstellung von diacetylrhein Process for the preparation of diacetylrhein |
| 01/07/1993 | CA2112376A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | CA2112375A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |